Table 4.
Multivariate Cox survival regression analysis
| Variable | B | SE | Wald | d.f. | P-value | Exp(B) | 95.0% CI for Exp(B)a |
|---|---|---|---|---|---|---|---|
| Age (cut-off value: 60 years) | −0.283 | 0.479 | 0.347 | 1 | 0.556 | 0.754 | 0.295–1.929 |
| Body mass index (cut-off value: 30) | −0.041 | 0.915 | 0.002 | 1 | 0.964 | 0.959 | 0.160–5.765 |
| Number of tumours (cut-off value: 3) | −11.176 | 238.273 | 0.002 | 1 | 0.963 | 0.000 | 0.000–1.800 (E202) |
| Presence of bilobar disease | 4.649 | 124.401 | 0.001 | 1 | 0.970 | 104.495 | 0.000–2.390 (E107) |
| Largest tumour diameter (cut-off value: 5 cm) | 0.880 | 0.654 | 1.808 | 1 | 0.179 | 2.410 | 0.669–8.688 |
| Venous tumour invasion | 6.104 | 213.578 | 0.001 | 1 | 0.970 | 447.535 | 0.000–2.810 (E184) |
| MELD score not adjusted for HCC (cut-off value: 10) | −0.098 | 0.905 | 0.012 | 1 | 0.914 | 0.907 | 0.154–5.341 |
| Serum AFP level (cut-off value: 100 ng/ml) | −0.207 | 0.534 | 0.150 | 1 | 0.699 | 0.813 | 0.285–2.318 |
a
Exponential terms.
SE, standard error; 95% CI, 95% confidence interval; MELD, Model for End-stage Liver Disease; HCC, hepatocellular carcinoma; AFP, alpha-fetoprotein.